ici 118551 and Carcinoma, Renal Cell

ici 118551 has been researched along with Carcinoma, Renal Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Albiñana, V; Botella, LM; Cuesta, AM; González-Peramato, P; Martinez-Piñeiro, L; Recio-Poveda, L	1

Other Studies

1 other study(ies) available for ici 118551 and Carcinoma, Renal Cell

Article	Year
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma. International journal of molecular sciences, 2022, Jan-25, Volume: 23, Issue:3 Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hemangioblastoma; Humans; Inflammation; Kidney Neoplasms; Male; Mice; Oxidative Stress; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Signal Transduction; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein	2022

Article

Year

Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.

International journal of molecular sciences, 2022, Jan-25, Volume: 23, Issue:3

Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hemangioblastoma; Humans; Inflammation; Kidney Neoplasms; Male; Mice; Oxidative Stress; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Signal Transduction; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein

2022